Maanav Nanda, CFA

MuReva is a medical device start-up located in Cleveland, OH with a mission to treat Oral Mucositis, a debilitating side effect of cancer treatment. Our patented device can treat and potentially prevent this terrible side effect that impacts over 3 million patients every year. Our investors, partners and employees are aggressively looking for others that want to contribute to a small company with a big mission.

Skin cancer is one of the most rapidly growing cancers worldwide, and early detection and diagnosis is crucial to reducing both morbidity and mortality, particularly for malignant melanoma. Yet, despite advances in medical technology, the process remains complex and time-consuming. Founded in 2017, Sklip is revolutionizing skin cancer detection by providing healthcare providers and patients with access to fast, accurate, and comprehensive skin cancer triage and diagnosis, and consumers with access to skin cancer screening. At the heart of our innovation is Sklip AI, our proprietary image-based artificial intelligence. Built on the global standard of care—dermoscopy—Sklip AI offers the highest reported clinical utility accuracy for skin cancer triage in the industry. What further set us apart is our use of proprietary biopsy tissue marking AI in our laboratories, which will provide full context and actionable insights to both healthcare providers and pathology laboratories, reduce tissue sampling bias, yield higher accuracy, and lessen delayed / inaccurate diagnoses. Sklip is poised to become the first company in the U.S. to offer both advanced digital health AI for skin cancer triage and integrated dermatology-specific pathology laboratory diagnostic services—creating a seamless, end-to-end solution for skin cancer detection and diagnosis. With our technology, we aim to address a critical gap in the healthcare system and drive significant improvements in early skin cancer detection and diagnosis. Join us in our mission to save lives and transform the future of skin cancer care.

Our goal is to create a culture of growth, technological advancement and more importantly, revolutionize the healthcare industry. In the 1920’s, archaeologists discovered the remains of a 4,600 year-old civilization in the Indus River Valley. The discovery was even more fascinating when it revealed that the inhabitants, a civilization known as the Harappans, focused their time, energy and resources on giving back to their community. In place of spending their resources on elaborate infrastructures and fancy statues, they found ways to advance the health and wellbeing of their people. ​ At Indus River Ventures, just like the Harappans, we are committed to using our time, money and resources on improving the lives of the one –third of the population who do not have access to healthcare. Through the advancements of technology and avenues of telemedicine we are dedicated to bringing disruptive changes to the healthcare industry. Indus River Ventures is devoted to the craftsmanship of our companies and extends the culture of excellence to all of our entities. Together we are bringing about a revolution, a revolution of a digital and connected healthcare industry.

MuReva is a medical device start-up located in Cleveland, OH with a mission to treat Oral Mucositis, a debilitating side effect of cancer treatment. Our patented device can treat and potentially prevent this terrible side effect that impacts over 3 million patients every year. Our investors, partners and employees are aggressively looking for others that want to contribute to a small company with a big mission.

Skin cancer is one of the most rapidly growing cancers worldwide, and early detection and diagnosis is crucial to reducing both morbidity and mortality, particularly for malignant melanoma. Yet, despite advances in medical technology, the process remains complex and time-consuming. Founded in 2017, Sklip is revolutionizing skin cancer detection by providing healthcare providers and patients with access to fast, accurate, and comprehensive skin cancer triage and diagnosis, and consumers with access to skin cancer screening. At the heart of our innovation is Sklip AI, our proprietary image-based artificial intelligence. Built on the global standard of care—dermoscopy—Sklip AI offers the highest reported clinical utility accuracy for skin cancer triage in the industry. What further set us apart is our use of proprietary biopsy tissue marking AI in our laboratories, which will provide full context and actionable insights to both healthcare providers and pathology laboratories, reduce tissue sampling bias, yield higher accuracy, and lessen delayed / inaccurate diagnoses. Sklip is poised to become the first company in the U.S. to offer both advanced digital health AI for skin cancer triage and integrated dermatology-specific pathology laboratory diagnostic services—creating a seamless, end-to-end solution for skin cancer detection and diagnosis. With our technology, we aim to address a critical gap in the healthcare system and drive significant improvements in early skin cancer detection and diagnosis. Join us in our mission to save lives and transform the future of skin cancer care.

This page is no longer active. National is now B. Riley Wealth. Please follow us at https://www.linkedin.com/company/brileywealthmanagement.